Large-scale, high-throughput production of rSIV.F/HN vectors

Large-scale, high-throughput production of rSIV.F/HN vectors

Dades bibliogràfiques
Autors principals:	Viegas, MFA, Gamlen, T, Conway, CC, Dean, RJ, Miah, KM, Hyde, SC, Gill, DR
Format:	Conference item
Idioma:	English
Publicat:	Cell Press 2020

Ítems similars

Rapid determination of rSIV.F/HN lentiviral vector titre
per: Conway, CC, et al.
Publicat: (2020)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
per: Gamlen, T, et al.
Publicat: (2020)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
per: Sergijenko, A, et al.
Publicat: (2021)

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
per: Pytel, K, et al.
Publicat: (2016)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
per: Hyde, S, et al.
Publicat: (2015)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
per: Gélinas, J, et al.
Publicat: (2017)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
per: Munday, RJ, et al.
Publicat: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
per: Munday, RJ, et al.
Publicat: (2022)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
per: Munday, RJ, et al.
Publicat: (2022)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
per: Ashworth, R, et al.
Publicat: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
per: Munday, R, et al.
Publicat: (2019)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
per: Pringle, I, et al.
Publicat: (2018)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
per: Pringle, I, et al.
Publicat: (2018)

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection
per: Yue, D, et al.
Publicat: (2022)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
per: Griesenbach, U, et al.
Publicat: (2012)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
per: Sergijenko, A, et al.
Publicat: (2020)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
per: Griesenbach, U, et al.
Publicat: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
per: Griesenbach, U, et al.
Publicat: (2012)

Lung-targeting lentiviral vector for passive immunisation against influenza
per: Tan, TK, et al.
Publicat: (2020)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
per: Rosie J. Munday, et al.
Publicat: (2022-09-01)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
per: Archana V. Boopathy, et al.
Publicat: (2023-11-01)

Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism
per: Joseph Antony
Publicat: (2019-12-01)

The Hemagglutinin-Neuraminidase (HN) Head Domain and the Fusion (F) Protein Stalk Domain of the Parainfluenza Viruses Affect the Specificity of the HN-F Interaction
per: Masato Tsurudome, et al.
Publicat: (2018-03-01)

hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
per: Indrani Talukdar, et al.
Publicat: (2011-01-01)

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge
Publicat: (2013-01-01)

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge.
per: Christopher T. Campbell, et al.
Publicat: (2013-01-01)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
per: Berkower I, et al.
Publicat: (2012-09-01)

Fourier transform of hn(x + p)hn(x − p)
per: Mourad E. H. Ismail, et al.
Publicat: (1997-01-01)

Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing.
Publicat: (2006-01-01)

Immunoinformatics approach for predicting epitopes in HN and F proteins of Porcine rubulavirus.
per: Luis I Siañez-Estrada, et al.
Publicat: (2020-01-01)

hnRNP F complexes with tristetraprolin and stimulates ARE-mRNA decay.
per: Boris Reznik, et al.
Publicat: (2014-01-01)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
per: Ping Zhang
Publicat: (2023-01-01)

Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates
per: Bhawna Sharma, et al.
Publicat: (2024-07-01)

Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
per: Roberta Bona, et al.
Publicat: (2021-12-01)

H.N. werkman /
per: 349092 Purvis, Alston W.
Publicat: (2004)

Hn-Domination in Graphs
per: Omran et al.
Publicat: (2019-03-01)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
per: Zhang X, et al.
Publicat: (2012-09-01)

Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
per: Penaloza MacMaster, P, et al.
Publicat: (2016)

A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.
per: Coles, J, et al.
Publicat: (2009)

Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F.
per: Erming Wang, et al.
Publicat: (2012-01-01)